Ex vivo expansion of hematopoietic stem cells: Concept and clinical benefit;Expansion ex vivo des cellules hematopoiétiques : concept et utilité clinique

Transfusion Clinique et Biologique

Volumn 16, Issue 5-6, 2009, Pages 489-500

  Ivanovic, Z ^a   Boiron, J M ^a,b  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Expansion; Hematopoietic progenitors; Stem cell; Transplantation

Indexed keywords

CD34 ANTIGEN;

BONE MARROW CELL; CELL CULTURE; CELL POPULATION; CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PERIPHERAL BLOOD STEM CELL; SHORT SURVEY; STEM CELL EXPANSION; STEM CELL MOBILIZATION; UMBILICAL CORD BLOOD;

ANIMALS; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; STEM CELLS;

EID: 71049121813     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2009.10.002     Document Type: Short Survey

References (78)

1. Verfaillie C.M. Can human hematopoietic stem cells be cultured ex vivo?. Stem Cells 12 (1994) 466-476
2. Boiron J.M., Dazey B., Cailliot C., Launay B., Attal M., Mazurier F., et al. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion 46 (2006) 1934-1942
3. Till J.E., and McCulloch E.A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14 (1961) 213-222
4. Constable T.B., and Blackett N.M. The relationship between granulocytic and erythroid repopulating ability. Exp Hematol 2 (1974) 131-137
5. Monette F.C. Cell amplification in erythropoiesis in vitro perspectives. Current Concepts. In: Dunn C.D.R. (Ed). Erythropoiesis (1983), John Wiley and Sons, Chichester 21-57
6. Ploemacher R.E., and Brons N.H. Isolation of hemopoietic stem cell subsets from murine bone marrow: I. Radioprotective ability of purified cell suspensions differing in the proportion of day-7 and day-12 CFU-S. Exp Hematol 16 (1988) 21-26
7. Ploemacher R.E., and Brons N.H. Isolation of hemopoietic stem cell subsets from murine bone marrow: II. Evidence for an early precursor of day-12 CFU-S and cells associated with radioprotective ability. Exp Hematol 16 (1988) 27-32
8. Neben S., Redfearn W.J., Parra M., Brecher G., and Pallavicini M.G. Short- and long-term repopulation of lethally irradiated mice by bone marrow stem cells enriched on the basis of light scatter and Hoechst 33342 fluorescence. Exp Hematol 19 (1991) 958-967
9. Keller G. Hematopoietic stem cells. Curr Opin Immunol 4 (1992) 133-139
10. Fibbe W.E., Zijlmans J.M., and Willemze R. Differential short-term and long-term repopulating ability of stem cell subsets in mice. Stem Cells 15 Suppl. 1 (1997) 47-51 [discussion 52-3]
11. Chertkov J.L., Drize N.J., Gurevitch O.A., and Samoylova R.S. Origin of hemopoietic stromal progenitor cells in chimeras. Exp Hematol 13 (1985) 1217-1222
12. Guenechea G., Gan O.I., Dorrell C., and Dick J.E. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2 (2001) 75-82
13. Weissman I.L., and Shizuru J.A. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 112 (2008) 3543-3553
14. Loeffler M., and Schmitz S. A concept of hemopoietic regulation and its biomathematical realization, Wichmann HE. Blood Cells 14 (1988) 411-429
15. Paré J.F., and Sherley J.L. Biological principles for ex vivo adult stem cell expansion. Curr Top Dev Biol 73 (2006) 141-171
16. McNiece I. Ex vivo expansion of hematopoietic cells. Part II: control of proliferation and differentiation of hematopoietic stem cells. Exp Hematol. 32 (2004) 692
17. Peled T., Glukhman E., Hasson N., Adi S., Assor H., Yudin D., et al. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. Exp Hematol 33 (2005) 1092-1100
18. Ivanovic Z., Duchez P., Dazey B., Hermitte F., Lamrissi-Garcia I., Mazurier F., et al. A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium. Transfusion 46 (2006) 126-131
19. Levac K., Karanu F., and Bhatia M. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo. Haematologica 90 (2005) 166-172
20. Möhle R., and Kanz L. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Semin Hematol 44 (2007) 193-202
21. McNiece I., Harrington J., Turney J., Kellner J., and Shpall E.J. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 6 (2004) 311-317
22. Andrade-Zaldívar H., Santos L., and De León Rodríguez A. Expansion of human hematopoietic stem cells for transplantation: trends and perspectives. Cytotechnology 56 (2008) 151-160
23. Douay L. Experimental culture conditions are critical for ex vivo expansion of hematopoietic cells. J Hematother Stem Cell Res 10 (2001) 341-346
24. Ivanovic Z. Interleukin-3 and ex vivo maintenance of hematopoietic stem cells: facts and controversies. Eur Cytokine Netw 15 (2004) 6-13
25. De Wynter E.A., and Testa N.G. Interest of cord blood stem cells. Biomed Pharmacother 55 (2001) 195-200
26. Kaushansky K. Thrombopoietin and the hematopoietic stem cell. Ann N Y Acad Sci 1044 (2005) 139-141
27. Piacibello W., Sanavio F., Garetto L., Severino A., Bergandi D., Ferrario J., et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89 (1997) 2644-2653
28. Luens K.M., Travis M.A., Chen B.P., Hill B.L., Scollay R., and Murray L.J. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone. Blood 91 (1998) 1206-1215
29. Herrera C., Sánchez J., Torres A., Bellido C., Rueda A., and Alvarez M.A. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice. Br J Haematol 114 (2001) 920-930
30. Reiffers J., Cailliot C., Dazey B., Attal M., Caraux J., and Boiron J.M. Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo expanded autologous CD34-positive cells. Lancet 354 (1999) 1092-1093
31. Csete M. Oxygen in the cultivation of stem cells. Ann N Y Acad Sci 1049 (2005) 1-8 [Review]
32. Ivanovic Z. Hypoxia or in situ normoxia: The stem cell paradigm. J Cell Physiol. 219 (2009) 271-275
33. Chow D.C., Wenning L.A., Miller W.M., and Papoutsakis E.T. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J 81 (2001) 685-696
34. 2 goes to: preservation of human fetal oxygen delivery and consumption at high altitude. J Physiol 587 (2009) 693-708
35. 2 concentration (3 %). Stem Cells 22 (2004) 716-724
36. Ivanović Z., Bartolozzi B., Bernabei P.A., Cipolleschi M.G., Rovida E., Milenković P., et al. Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. Br J Haematol 108 (2000) 424-429
37. Fan J., Cai H., and Tan W.S.J. Role of the plasma membrane ROS-generating NADPH oxidase in CD34+ progenitor cells preservation by hypoxia. Biotechnology 130 (2007) 455-462
38. Fan J., Cai H., Yang S., Yan L., and Tan W. Comparison between the effects of normoxia and hypoxia on antioxidant enzymes and glutathione redox state in ex vivo culture of CD34(+) cells. Comp Biochem Physiol B Biochem Mol Biol 151 (2008) 153-158
39. Fan JL, Cai HB, Tan WS. Effect of regulating intracellular ROS with antioxidants on the ex vivo expansion of cord blood CD34(+) cells, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (Chin Jl). Cell Molec Physiol 2008a;24:767-70.
40. Prus E., and Fibach E. The effect of the copper chelator tetraethylenepentamine on reactive oxygen species generation by human hematopoietic progenitor cells. Stem Cells Dev 16 (2007) 1053-1056
41. Yoshida K., Kirito K., Yongzhen H., Ozawa K., Kaushansky K., and Komatsu N. Thrombopoietin (TPO) regulates HIF-1alpha levels through generation of mitochondrial reactive oxygen species. Int J Hematol 88 (2008) 43-51
42. Metcalf D. Hematopoietic cytokines. Blood 111 (2008) 485-491
43. Prasad S.M., Czepiel M., Cetinkaya C., Smigielska K., Weli S.C., Lysdahl H., et al. Continuous hypoxic culturing maintains activation of Notch and allows long-term propagation of human embryonic stem cells without spontaneous differentiation. Cell Prolif 42 (2009) 63-74
44. Campbell C., Risueno R.M., Salati S., Guezguez B., and Bhatia M. Signal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects. Curr Opin Hematol 15 (2008) 319-325
45. Tanaka H., Matsumura I., Itoh K., Hatsuyama A., Shikamura M., Satoh Y., et al. HOX decoy peptide enhances the ex vivo expansion of human umbilical cord blood CD34+ hematopoietic stem cells/hematopoietic progenitor cells. Stem Cells 24 (2006) 2592-2602
46. Dickson G.J., Kwasniewska A., Mills K.I., Lappin T.R., and Thompson A. Hoxa6 potentiates short-term hemopoietic cell proliferation and extended self-renewal. Exp Hematol 37 (2009) 322-333
47. Antonchuk J., Sauvageau G., and Humpries R.K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109 (2002) 39-45
48. Amsellem S., Pflumio F., Bardiner D., Izac B., Charneau P., Romeo P.-H., et al. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nature Med 9 (2003) 1423-1427
49. Delaney C., Varnum-Finney B., Aoyama K., Brasham-Stein C., and Bernstein I.D. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. Blood 106 (2005) 2693-2699
50. Kanold J., Halle P., Tchirkov A., Berger M., Giarratana M.C., Kobari L., et al. Ex vivo expansion of autologous PB CD34+ cells provides a purging effect in children with neuroblastoma. Bone Marrow Transplant 32 (2003) 485-488
51. Vogel W., Behringer D., Scheding S., Kanz L., and Brugger W. Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells. Blood 88 (1996) 2707-2713
52. Osawa M., Hanada K., Hamada H., and Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273 (1996) 242-245
53. Nakamura Y., Ando K., Chargui J., Kawada H., Sato T., Tsuji T., et al. Ex vivo generation of CD34(+) cells from CD34(-) hematopoietic cells. Blood 94 (1999) 4053-4059
54. Holyoake T.L., Alcorn M.J., Richmond L., Farrell E., Pearson C., Green R., et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant 19 (1997) 1095-1101
55. Donaldson C., Denning-Kendall P., Bradley B., and Hows J. The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function. Bone Marrow Transplant 27 (2001) 365-371
56. Dao M.A., Arevalo J., and Nolta J.A. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 101 (2003) 112-118
57. McNiece I., Jones R., Bearman S.I., Cagnoni P., Nieto Y., Franklin W., et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 96 (2000) 3001-3007
58. Bachier C.R., Gokmen E., Teale J., Lanzkron S., Childs C., Franklin W., et al. Ex vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer. Exp Hematol 27 (1999) 615-623
59. Stiff P., Chen B., Franklin W., Oldenberg D., Hsi E., Bayer R., et al. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 95 (2000) 2169-2174
60. Engelhardt M., Douville J., Behringer D., Jähne A., Smith A., Henschler R., et al. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy. Bone Marrow Transplant 27 (2001) 249-259
61. Pecora A.L., Stiff P., LeMaistre C.F., Bayer R., Bachier C., Goldberg S.L., et al. A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation. Bone Marrow Transplant 28 (2001) 295-303
62. Brugger W., Heimfeld S., Berenson R.J., Mertelsmann R., and Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333 (1995) 283-287
63. Williams S.F., Lee W.J., Bender J.G., Zimmerman T., Swinney P., Blake M., et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 87 (1996) 1687-1691
64. Prince H.M., Simmons P.J., Whitty G., Wall D.P., Barber L., Toner G.C., et al. Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells. Br J Haematol 126 (2004) 536-545
65. Paquette R.L., Dergham S.T., Karpf E., Wang H.J., Slamon D.J., Souza L., et al. Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 96 (2000) 2385-2390
66. Paquette R.L., Dergham S.T., Karpf E., Wang H.J., Slamon D.J., Souza L., et al. Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery. Exp Hematol 30 (2002) 374-380
67. Ivanovic Z, Dazey B, Duchez P, Lafarge X, Rossi F, Reiffers J, et al. La thrombopoïétine de grade Clinique peut remplacer le MGDF dans l'expansion ex vivo des cellules souches et progénitrices hématopoïètiques. (22 Congers SFTS, Saint-Malo 2005). Transf Clin Biol 2005;12 (Suppl. 1):S95 [Abstr. P106].
68. Reichle A., Zaiss M., Rothe G., Schmitz G., and Andreesen R. Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells. Bone Marrow Transplant 32 (2003) 299-305
69. Kögler G., Nürnberger W., Fischer J., Niehues T., Somville T., Göbel U., et al. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia. Bone Marrow Transplant 24 (1999) 397-403
70. Pecora A.L., Stiff P., Jennis A., Goldberg S., Rosenbluth R., Price P., et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 25 (2000) 797-799
71. Fernández M.N., Regidor C., Cabrera R., García-Marco J., Briz M., Forés R., et al. Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant 28 (2001) 355-363
72. Shpall E.J., Quinones R., Giller R., Zeng C., Baron A.E., Jones R.B., et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 8 (2002) 368-376
73. Jaroscak J., Goltry K., Smith A., Waters-Pick B., Martin P.L., Driscoll T.A., et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 101 (2003) 5061-5067
74. de Lima M., McMannis J., Gee A., Komanduri K., Couriel D., Andersson B.S., et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant 41 (2008) 771-778
75. Duchez P., Dazey B., Douay L., Vezon G., and Ivanovic Z. An efficient large-scale thawing procedure for cord blood cells destined for selection and ex vivo expansion of CD34+ cells. J Hematother Stem Cell Res 12 (2003) 587-589
76. Dazey B., Duchez P., Letellier C., Vezon G., and Ivanovic Z. Cord blood processing by using a standard manual technique and automated closed system "Sepax" (Kit CS-530). French Cord Blood Network. Stem Cells Dev 14 (2005) 6-10
77. Kobari L., Pflumio F., Giarratana M., Li X., Titeux M., Izac B., et al. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells. Exp Hematol 28 (2000) 1470-1480
78. Ivanovic Z, Duchez P, Chevaleyre J, Vlaski M, Dazey B, Lafarge X, et al. Maintenance of primitive stem cell activity during massive amplification of committed progenitors in clinical scale serum-free ex vivo cultures of thawed cord blood CD34+ cells. (13th Congress of the EHA, Copanhagen 2008). Haematologica 2008;93(S1):131 [Abstr. 0321;].